Royal Bank of Canada’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,454
| Closed | -$1.34M | – | 7358 |
|
|
2023
Q1 | $1.34M | Sell |
12,454
-2,195
| -15% | -$236K | ﹤0.01% | 2811 |
|
|
2022
Q4 | $1.61M | Sell |
14,649
-1,891
| -11% | -$208K | ﹤0.01% | 2719 |
|
|
2022
Q3 | $976K | Buy |
16,540
+15,524
| +1,528% | +$916K | ﹤0.01% | 3047 |
|
|
2022
Q2 | $29K | Sell |
1,016
-1,426
| -58% | -$40.7K | ﹤0.01% | 5490 |
|
|
2022
Q1 | $93K | Sell |
2,442
-3,884
| -61% | -$148K | ﹤0.01% | 5236 |
|
|
2021
Q4 | $251K | Buy |
6,326
+4,649
| +277% | +$184K | ﹤0.01% | 4591 |
|
|
2021
Q3 | $39K | Buy |
1,677
+904
| +117% | +$21K | ﹤0.01% | 5788 |
|
|
2021
Q2 | $19K | Buy |
+773
| New | +$19K | ﹤0.01% | 6097 |
|